The U.S. Food and Drug Administration (FDA) has approved a new drug, tarlatamab (Imdelltra), for treating patients with an advanced and deadly form of lung cancer. Breakthrough Treatment for Small Cell Lung Cancer This approval is particularly significant for those suffering from extensive-stage small cell lung cancer (ES-SCLC) who have exhausted all other treatment options. … Read more